GlassScriptPhysician profile
Tara H Olson
NPI 1104184654
$298.35
in general payments reported to CMS, 2019-2025
8 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.55 · 2023: $76.30 · 2024: $75.01 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $91.41 | 2025 | |
| Myriad Women'S Health, INC. | $58.19 | 2023 | Myrisk |
| Aspira Women'S Health INC | $50.69 | 2023-2024 | Ova1 |
| Sage Therapeutics, LLC | $21.39 | 2024 | |
| Seqirus USA INC | $21.17 | 2025 | Flucelvax, Fluad |
| Sumitomo Pharma America, INC. | $21.04 | 2024 | Gemtesa |
| Astellas Pharma US INC | $17.91 | 2025 | Veozah |
| Abbvie INC. | $16.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.